Publication | Closed Access
Activation of Factor X
25
Citations
0
References
1965
Year
ImmunohematologyImmunologyFactor ViiPathologyFactor XThrombosisBioanalysisHematologyCellular Regulatory MechanismPurified ProthrombinCell SignalingChromatographyHealth SciencesMolecular PhysiologyFunctional RegulationPharmacologyCell BiologySignal TransductionBlood PlateletHemostasisCoagulopathyMedicine
Summary 1. Methods have been developed for the preparation of factor VII free of prothrombin and factor X, and of factor X with only a very low contamination with factor VII. 2. Factors VII and X could be found with one stage methods in purified prothrombin prepared according to Seegers. 3. Purified prothrombin was chromatographed on DE AE-cellulose. Two active fractions could be eluted, the first with the characteristics of Seegers’ DE AE-Prothrombin, the second with the characteristics of factor X. 4. It was confirmed that DE AE-Prothrombin does not activate to thrombin in 25% citrate, and does not generate autoprothrombin C. 5. The combination of both clotting active fractions coming from the DEAE-column restores the properties of non-chromatographed prothrombin. 6. DE AE-cellulose chromatography of prothrombin does not induce a molecular change of prothrombin, but separates factor X from prothrombin. 7. Factor X can be activated with tissue thromboplastin-factor VII or with high concentrated neutral salt solutions to a substance with the biological characteristics of autoprothrombin C. 8. TAMe activity is generated in factor X preparations after incubation with tissue thromboplastin and calcium. 9. Factor VII cannot be transformed into autoprothrombin C under the conditions tested. 10. Factor VII is necessary for the activation of factor X with tissue thromboplastin but not with RVV. 11. The amount of factor X available determines the amount of autoprothrombin C formed, whereas thromboplastin and factor VII influence the rate of the reaction. 12. The final conclusion is that activated factor X is similar to or identical with autoprothrombin C.